8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): October 5, 2007

VITAL SIGNS, INC.

(Exact Name of Registrant as Specified in its Charter)

New Jersey	0-18793	11-2279807
(State or Other Jurisdiction	(Commission File Number)	(IRS Employer
of Incorporation)		Identification No.)
20 Campus Road, Totowa, New Jersey		07512
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (973) 790-1330

      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

      [  ]    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

      [  ]    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

      [  ]    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

      [  ]    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

      On October 10, 2007, Vital Signs, Inc. issued a press release announcing that Mark D. Mishler will be joining Vital Signs as its Executive Vice President and Chief Financial Officer on approximately November 1, 2007. Mr. Mishler is joining Vital Signs from his current position as Corporate Controller of Fedders Corporation.

      William Craig resigned as the Company’s Chief Financial Officer effective October 5, 2007, to take a position with an investment firm.

      A copy of the press release disclosing these events is attached to this Current Report on Form 8-K as Exhibit 99.1.

     Item 9.01 Financial Statements and Exhibits.

(d)	Exhibits
	99.1 Press release, dated October 10, 2007

-2-

SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

VITAL SIGNS, INC.

By: /s/ Jay Sturm                                   
       Name: Jay Sturm
       Title: Vice President / General Counsel

Dated: October 10, 2007

-3-

EX-99.1

Exhibit 99.1 Press Release, dated October 10, 2007

VITAL SIGNS ANNOUNCES APPOINTMENT OF CHIEF FINANCIAL OFFICER

     TOTOWA, N.J., October 10, 2007 -- VITAL SIGNS, INC. (NASDAQ: VITL) today announced that Mark D. Mishler will be joining the company as its Executive Vice President and Chief Financial Officer. Mr. Mishler joins Vital Signs from his current position as Corporate Controller of Fedders Corporation. Mr. Mishler is a certified public accountant and a certified management accountant. He holds Bachelors of Arts degrees in chemistry and biology from Indiana University and a Masters in Business Administration from the University of Michigan. Mr. Mishler is assisting his current employer with certain transition activities and will begin his employment with Vital Signs approximately November 1^st.

     William Craig has resigned as the Company’s Chief Financial Officer effective October 5, 2007. Mr. Craig is leaving Vital Signs to take a position with Fifth Street Capital, a mezzanine investment firm.

     Terry Wall, Chief Executive Officer, commented, “We are extremely pleased to have recruited an individual of Mark’s caliber and we believe he will bring valuable insights and knowledge to our team.” Mr. Wall added, “Vital Signs would like to extend its best wishes to Bill for success in his new position and to thank him for his efforts on behalf of Vital Signs.”

     Vital Signs, Inc. and its subsidiaries design, manufacture and market primarily single-use medical products for the anesthesia, respiratory/critical care, interventional cardiology/radiology and sleep/ventilation markets, achieving the number one market share position in five of its major product categories. Vital Signs is ISO 9001 certified and has CE Mark approval for its products. In 2006 Forbes Magazine named Vital Signs, Inc. as “one of the 200 Best Small Companies in America” based on financial criteria.

      All statements in this press release other than historical statements constitute Forward Looking Statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements as a result of a variety of factors including factors referred to by Vital Signs in its Annual Report on Form 10-K for the year ended September 30, 2006.

FOR FURTHER INFORMATION, CONTACT:	Terry D. Wall, President
	or
	Douglas Wall, Investor Relations
	(973) 790-1330
	http://www.vital-signs.com